Finney JMT. Gastro-enterostomy for cicatrizing ulcer of the pylorus. Johns Hopkins Hosp Bull. 1893. 4:53-55.
Hall IC, O'Toole E. Intestinal flora in new-born infants. Am J Dis Child. 1935. 49:390-402.
Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015 Jan 27. 313 (4):398-408. [QxMD MEDLINE Link].
McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008 Oct. 3 (5):563-78. [QxMD MEDLINE Link].
Indra A, Lassnig H, Baliko N, Much P, Fiedler A, Huhulescu S, et al. Clostridium difficile: a new zoonotic agent?. Wien Klin Wochenschr. 2009. 121 (3-4):91-5. [QxMD MEDLINE Link].
Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery. 2008 May. 143 (5):623-9. [QxMD MEDLINE Link].
Mitas L, Svaton R, Skricka T, Kala Z, Penka I, Hanslianov M, et al. Surgical treatment of Clostridium colitides. Acta Chir Iugosl. 2012. 59 (2):63-9. [QxMD MEDLINE Link].
Earhart MM. The identification and treatment of toxic megacolon secondary to pseudomembranous colitis. Dimens Crit Care Nurs. 2008 Nov-Dec. 27 (6):249-54. [QxMD MEDLINE Link].
Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009 Mar 4. 301 (9):954-62. [QxMD MEDLINE Link].
Zheng L, Keller SF, Lyerly DM, Carman RJ, Genheimer CW, Gleaves CA, et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol. 2004 Aug. 42 (8):3837-40. [QxMD MEDLINE Link].
Vigna SR. 5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats. Int J Inflam. 2014. 2014:389621. [QxMD MEDLINE Link].
McVey DC, Liddle RA, Riggs-Sauthier J, Ekwuribe N, Vigna SR. Inhibition of Clostridium difficile toxin A-induced colitis in rats by APAZA. Dig Dis Sci. 2005 Mar. 50 (3):565-73. [QxMD MEDLINE Link].
Vigna SR. Intraluminal Administration of Resiniferatoxin Protects against Clostridium difficile Toxin A-Induced Colitis. Gastroenterol Res Pract. 2017. 2017:8438172. [QxMD MEDLINE Link]. [Full Text].
[Guideline] McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19. 66 (7):e1-e48. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019. 14:8. [QxMD MEDLINE Link]. [Full Text].
Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol. 2013 Jul 1. 31 (19):2493-9. [QxMD MEDLINE Link].
Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, et al. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. Am J Infect Control. 2007 Mar. 35 (2):131-7. [QxMD MEDLINE Link].
Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997 Sep. 41 (3):366-70. [QxMD MEDLINE Link]. [Full Text].
Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013 Apr. 108 (4):500-8. [QxMD MEDLINE Link].
Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, et al. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study. Am J Gastroenterol. 2017 Jun. 112 (6):940-947. [QxMD MEDLINE Link].
Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015 May. 41 (9):835-43. [QxMD MEDLINE Link].
Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015 May 5. 313 (17):1719-27. [QxMD MEDLINE Link].
Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004 Oct. 47 (10):1620-6. [QxMD MEDLINE Link].
Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011 Sep. 254 (3):423-7; discussion 427-9. [QxMD MEDLINE Link].
Ahmed N, Kuo YH. Early Colectomy Saves Lives in Toxic Megacolon Due to Clostridium difficile Infection. South Med J. 2020 Jul. 113 (7):345-349. [QxMD MEDLINE Link].
Ferrada P, Callcut R, Zielinski MD, Bruns B, Yeh DD, Zakrison TL, et al. Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile-associated disease: An Eastern Association for the Surgery of Trauma multicenter trial. J Trauma Acute Care Surg. 2017 Jul. 83 (1):36-40. [QxMD MEDLINE Link].
Shellito AD, Russell MM. Diverting Loop Ileostomy for Clostridium Difficile Colitis: A Systematic Review and Meta-analysis. Am Surg. 2020 Oct. 86 (10):1269-1276. [QxMD MEDLINE Link].
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, et al. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 Jan 26. 376 (4):305-317. [QxMD MEDLINE Link]. [Full Text].